Skip to main content
Toggle navigation
Login
Search
Home
ICPE 2023 Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Poster Title
Browse by Poster Title
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Sort by
#
Sort by
Title
D
086
Data Cleaning to Estimate Dosing Frequency of Zoledronic Acid
Favorite
226
Data Stewardship and its Role in Ensuring Real-World Data Quality and Methodological Rigor in Research
Favorite
131
Database profile: EPI-MERES, a nationwide mother-child register built from the French National Health Data System (SNDS) for pregnancy and paediatric pharmacoepidemiological research
Favorite
247
Day-to-Day Variability in Sleep Parameters and Sleep Impairment Among Adolescents With Mood Disorders Treated With Antidepressants
Favorite
256
Dealing with time-varying treatments in observational studies: a qualitative methodological review and proposal of research framework
Favorite
A43
Decreased Venous Thromboembolic Risk of Estradiol Valerate/Dienogest COCs Compared to First-line COCs Containing Ethinyl Estradiol/Levonorgestrel: Pooled Analysis in a Large Real-World User Population
Favorite
055
Defining Key Deprescribing Measures From Electronic Health Data: Learnings From A Multisite Data Harmonization Project
Favorite
222
Defining Provider Prescribing Preference as an Instrumental Variable: A Case Study of NOACs in Stroke Prevention
Favorite
083
Definitions of Long COVID Among Published Research Studies
Favorite
131
Depression among Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) Patients before and during the COVID-19 Pandemic Era: a US-claims Based Analysis
Favorite
105
Describing Adjuvant Chemotherapy Delivery in Older and Younger Women with Early-Stage Breast Cancer Using Longitudinal Cumulative Dose
Favorite
200
Describing clinical outcomes in adults hospitalized with viral lung infections using US real-world data
Favorite
039
Describing medication changes near end-of-life: Applied example and methodological considerations
Favorite
202
Describing trends in hypertension-diabetes comorbidity in United States adults from 2008 to 2022 using Real World Data
Favorite
068
Descriptive Analysis of Safety of Ketamine Utilizing FDA Adverse Events Reporting System FAERS Database
Favorite
185
Descriptive Characteristics and Validation of Fibrotic Interstitial Lung Disease Patients (ILD) with and without progression Using a Claims Based Algorithm
Favorite
173
Descriptive Epidemiology of Adult T-cell Leukemia/Lymphoma in the United States
Favorite
181
Descriptive Epidemiology of Peripheral T-Cell Lymphoma in the United States
Favorite
249
Detecting digital illness threat using an anomaly detection approach in the United States
Favorite
110
Determinants of Participation in Clinical Trials During Pregnancy and Lactation
Favorite
180
Determination of patients’ quality of life (QOL) and its influencing risk factors associated with QOL in patients with autoimmune systemic vasculitis: a cross-sectional study
Favorite
071
Determination of Pill-Burden and Its Association with Treatment Burden among Patients with Advanced Stages of Chronic Kidney Disease in Qatar
Favorite
234
Developing a perinatal extension for the OMOP common data model
Favorite
028
Development and Implementation of the National Clozapine Safety System for the Department of Veterans Affairs
Favorite
261
Development and Validation of a Claims-based Algorithm for Moderate-to-Severe Atopic Dermatitis
Favorite
189
Development and validation of a claims-based definitional algorithm for moderate asthma exacerbations
Favorite
151
Development and validation of a risk prediction model for estimating the disease progression in patients with NAFLD
Favorite
266
Development and Validation of a Tool to Assess Perceptions, Perspectives, Practice and Satisfaction in Patients Taking Oral anticoagulants
Favorite
246
Development and Validation of Algorithms to Identify Endometrial Carcinoma Using ICD-9 and ICD-10 Codes in a US Healthcare Claims Database
Favorite
272
Development and Validation of Claims-based Algorithms for Conjunctivitis and Keratitis
Favorite
030
Development and validation of technology assisted tool for Data mining of public version of FAERS database using python language
Favorite
228
Development of a risk categorization framework to quantify antimicrobial resistance risk in female patients with uncomplicated urinary tract infection
Favorite
219
Development of Audit Readiness Considerations of Real-World Data for Use in Regulatory Decision-Making
Favorite
217
Development of Computable Operational Definitions to Maximize Comparability & Consistency Across a Multi-Data Source Global Real-World Effectiveness Program
Favorite
102
Development of Drug Trees to Support TreeScan Analyses of Prenatal Drug Exposures Associated with Fetal Cardiac Malformations
Favorite
C09
Diabetes medication use in digital hospitals in China: a cross-sectional descriptive study
Favorite
A36
Diagnosed Prevalence of Hypophosphatasia in the United States: a Real World Analysis of Electronic Health Records
Favorite
046
Differences in Time to Onset Between Spontaneous Reports and Cohort Studies: The Case of the COVID-19 Vaccines
Favorite
B04
Direct Medical Cost Associated with Antiplatelet Non-persistence in Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention
Favorite
219
Discharging postoperative patients with an opioid prescription may result in greater reliance on opioid itself and increased healthcare expenditure and mortality
Favorite
042
Discontinuation rate to biologic and targeted synthetic DMARDs in rheumatoid arthritis patients: systematic review and meta-analysis
Favorite
059
Discovering the Risk Factors of the COVID-19 Vaccine-induced Carditis applying the Machine Learning Approach: Based on Real World Data
Favorite
232
Disease relapse, adverse events and all-cause mortality associated with the use of long-acting injectable antipsychotics versus oral antipsychotics in older people with schizophrenia: a self-controlled case series study
Favorite
B19
Disease severity profile and treatment switch patterns as treatment response proxy in Crohn’s disease population using Optum databases
Favorite
A01
Disparities in Guideline-Recommended Pharmacotherapy for Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and Sex: A Nationally Representative Cross-Sectional Analysis of Adults in the United States
Favorite
117
Disparities in prescriptions medications use by socioeconomic status and geographical location during COVID-19 pandemic
Favorite
123
Disparity in guideline-based antidiabetic drugs prescribing for type 2 diabetes patients in primary healthcare facilities across China, 2017-2019
Favorite
039
Dispensation of Biologic and Non-Biologic Medication in the Brazilian Public Health System
Favorite
140
Disruptions In Prenatal Care Visits During The Pandemic: A Population-Based Cohort Study in Manitoba, Canada
Favorite
232
Diversifying the FDA’s Sentinel System with Rigorous Quality Inclusion Rules for the U.S. Medicaid Population
Favorite
C17
Do Enrollment Gaps Matter? A Real-World Study of Administrative Health Claims Gaps Using the Sentinel Common Data Model
Favorite
288
Do’s and Don’ts for the European Community Pharmacist When Dispensing Antibiotics: A Delphi Study
Favorite
058
Dosing of cannabinoids associated with an opioid-sparing effect: A systematic review of longitudinal studies
Favorite
071
Drug Plan Monitoring of Paxlovid Adherence and Patient-Reported Adverse Events in British Columbia
Favorite
076
Drug Repurposing for Hepatocellular Carcinoma via Real World Data Corroborated with Bioinformatics
Favorite
294
Drug use evaluation comparing sedative-hypnotic drug use in hospitalized inpatients in two Canadian community hospitals
Favorite
167
Drug use in presence of contraindications in MG patients in three Italian Regions: a real-world observational study in Italy - The CAESAR study
Favorite
101
Drug utilisation studies in pregnant women for newly licensed medicinal products: reflections from IMI-ConcePTION
Favorite
032
Drug Utilization Evaluation of Narrow Therapeutic Index Drugs in A Tertiary Care Teaching Hospital
Favorite
056
Drug Utilization of Biologic Therapy for Inflammatory Bowel Disease Using Data of An Brazilian Healthcare Administrative Database (2008-2021)
Favorite
C18
Drug Utilization Patterns among Patients Hospitalized with COVID-19 in the United States, January 2021– February 2022
Favorite
115
Drug-Drug Interactions and Adverse Drug Reaction Hospital Admissions in the Older Population: A Prospective Cohort Study
Favorite
182
Dynamic Change in HBsAg in Chronic Hepatitis B Patients Receiving Nucleos(t)ide Analogues in China
Favorite
